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Abstract
Background: Severe anaemia is a common cause for hospitalization in children in sub-Saharan Africa. Malaria plays
an important aetiological role, resulting in a substantial burden of paediatric transfusion in hospitals. A decline in
malaria and paediatric admissions to the Kilifi District Hospital has been reported recently. This study aimed to
investigate whether this trend affected clinical burden, clinical severity of anaemia and requirements for paediatric
transfusion.
Methods: Eight-year retrospective review of paediatric admissions to Kilifi District Hospital, Kenya describing the
frequency of moderate and severe anaemia, blood transfusion and case fatality over time. Definitions for severe
anaemia were Hb <8 g/dl for newborns and <5 g/dl for other age groups and for moderate anaemia was Hb 8 to
<11 g/dl for newborns and 5 to <9.3 g/dl for other age groups. Life threatening anaemia was defined as severe
anaemia (Hb <5 g/dl) complicated by either deep breathing or prostration or profound anaemia (Hb <4 g/dl) alone.
Results: Of the 35,139 admissions 13,037 (37%) had moderate anaemia and 2,265 (6%) had severe anaemia;
respiratory distress complicated 35% of cases with Hb <5 g/dl. Concurrent with the decline in malaria there was a
marked decline in the prevalence of severe anaemia between 2002 (8%) and 2009 (< 4%) (chi2 for trend = 134,
P < 0.0001). The number and proportion of admissions transfused also declined significantly over this time (chi2 for
trend = 152, P < 0.0001). Of the 2,265 children with severe anaemia 191 (8%) died. Case fatality remained
unchanged during this period (P < 0.26) and was largely explained by the unchanged proportion with life-
threatening anaemia, present in 58-65% of cases throughout the study period.
Conclusion: The impact of reduced malaria transmission on child morbidity has positive public benefits on the
demand and use of blood for paediatric transfusion. Despite an overall reduction in paediatric transfusion
requirement, case fatality of severe anaemia remained unchanged over this decade. Further research is required to
improve outcome from severe anaemia, particularly in the high-risk group with life threatening features.
Background
In sub-Saharan Africa severe anaemia is a leading cause
of paediatric admission to hospital. The community pre-
valence of anaemia in African children, defined as a hae-
moglobin (Hb) <11 g/dl, ranges from 49% to 89% and
severe anaemia (variously defined as Hb <5 g/dl, <6 g/dl
or Hb <7 g/dl) affects between 1%- 6% of children, with
infants being the most vulnerable age group [1]. In hos-
pitalized children the prevalence of severe anaemia
ranges from 8 - 29% [2,3], resulting in a high demand
for blood transfusion, thus in malaria-endemic Africa
paediatric transfusion accounts for up to 70% of all
transfusions prescribed [4].
The aetiology of anaemia is frequently multifactorial [5],
commonly associated with Plasmodium falciparum
malaria infection [6] and nutritional factors in children
admitted to hospital [2,7]. The relative risk of in-hospital
mortality for children with severe anaemia is almost twice
that of their less anaemic counterparts [2]. Despite the
provision of blood transfusion, the case fatality of children
with severe anaemia remains high. Over 50% of deaths
occurring within hours of admission with a number
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occurring in children awaiting urgent transfusion [7,8].
Blood transfusion is the definitive and life-saving treat-
ment for acute severe anaemia, resulting in substantial
benefit in children with profound anaemia (Hb < 4 g/dl)
and children with Hb 4-6 g/dl with severe complications
(prostration or deep breathing) [8,9]. However, the major-
ity of transfusions are received by children with severe
anaemia (Hb 4-6 g/dl) without life-threatening signs for
whom the benefits of urgent transfusion are unproven
[10-12]. WHO recommends avoidance of blood transfu-
sion in this group to protect supplies of blood and reduce
the risk of adverse reactions and transfusion transmitted
infections [4]. Post-discharge morbidity and mortality are
important considerations in this group but there are few
data on the cumulative incidence of poor outcomes over
the longer-term [13].
Despite these guidelines being in place for many years
in Africa, up to 50% of hospitalized children in malaria
endemic receive a blood transfusion [13]. Malaria still
plays an important role in the onset of severe anaemia,
placing a limitation on the ability to reduce the need for
paediatric transfusion in hospitals in malaria endemic
areas. In Kilifi District Hospital (KDH), Kenya’s coast,
the policy of restrictive blood transfusion practice has
been applied since the late 1990’s. English et al evalu-
ated the practice between 1998 and 2000 and found that
13% of all paediatric admissions (excluding newborns)
were transfused [8]. Malaria and severe malnutrition
were the main primary diagnoses. In recent years, a
decline in malaria and paediatric admissions to the hos-
pital has been reported [14]. This review aimed to inves-
tigate whether this trend also affected transfusion
practice and requirements for paediatric and neonatal
transfusion.
Methods
A retrospective study of hospital admissions to address the
following specific objectives. First, to describe the propor-
tions of anaemia and blood transfusions secondary to
malaria and describe the changes over time. Secondly, to
examine compliance with the threshold for blood transfu-
sion, established by the World Health Organization
(WHO) current transfusion guidelines, and finally, to
determine in-hospital survival. Retrospective data review
of the clinical surveillance database covering all child and
neonatal admissions to Kilifi District Hospital (KDH),
Kenya, over an 8-year period, from January 2002 to
December 2009. Clinical data are routinely collected pro-
spectively at admission and directly entered into a File-
maker Pro® database, which is password-protected and has
limited access. Data on the following were retrieved; age,
sex, diagnosis, falciparum malaria parasitaemia, haemoglo-
bin (Hb) level, respiratory distress, level of consciousness,
nutritional status, capillary refill > 2 seconds (as a sign of
hypovolvaemic shock) together with data on blood trans-
fusion, length of stay and mortality as outcome variables.
Kilifi District is one of the poorest area in Kenya,
where malaria is endemic, with 40% of children under
five years presenting anthropometric measures of mal-
nutrition, half with biochemical markers of iron defi-
ciency, 14% of children have a sickle cell trait and nearly
60% have a+ thalassaemia deletion genotypes [11].
Analysis
Proportions of transfusions due to malaria and other
diagnoses were calculated for each year and the propor-
tions compared over time. Since transfusion thresholds
are different for neonates, we analysed the trends in
neonates separately from those of older children. Chil-
dren outside the neonatal period (≥ 1 month) were
further sub-grouped into infants (1-12 months), 1-4
years, and older then 5 years since the prevalence of
severe malaria anaemia varies considerably over these
age groups. The children were further categorised by
their clinical severity features.
Severe anaemia was defined as Hb <8 g/dl for neonates
and <5 g/dl for other age groups; profound anaemia in
non-neonatal groups was defined as Hb <4 g/dl. As
defined by WHO criteria for anaemia: moderate anaemia
was a Hb 8 - <11 g/dl for newborns and 5 - <9.3 g/dl for
other age groups; .mild or no anaemia as Hb >11 g/dl for
newborns and > 9.3 g/dl for other age groups. Respira-
tory distress was defined as either the presence of deep
breathing (a clinical feature of metabolic acidosis) or
indrawing. Nutritional status was measured by the para-
meter birth weight or gestational age for neonates (severe
malnutrition was equivalent to prematurity or small for
gestational age). For the other age groups severe malnu-
trition was defined as either mid upper arm circumfer-
ence (MUAC) <11 cm and/or presence of oedema
(kwashiorkor). Impaired consciousness indicated the pre-
sence of prostration (inability to sit unsupported if > 9
months or inability to breast feed if ≤ 9 months). Life-
threatening anaemia was defined as either profound
anaemia (Hb <4 g/dl) irrespective of clinical severity or
severe anaemia (Hb <5 g/dl) complicated by deep breath-
ing or prostration. Stata version 11 (Stata corporation,
Texas, United States) was used for data analysis for
descriptive statistics.
Results
Over the eight year period 36,621 children <13 years
were admitted. Admission haemoglobin (Hb) was avail-
able for 35,139 and missing in 1482 (3.9%). Moderate
anaemia occured in 13,037 (37%) and 2,265 (6%) had
severe anaemia (Table 1). Severe anaemia was common-
est in children 1-12 years (8%) and less prevalent in new-
borns, with only 91 (2%) cases being affected. Respiratory
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distress complicated 35% of cases with Hb <5 g/dl, and
was more prevalent in infants and newborn. Concomitant
malaria parasitaemia, rarely present in neonates, was
common in all other age groups but its prevalence was
more closely tied to the year of study than age. Over the
study period there was a significant decline in malaria
across all ages groups (Figure 1) (chi2 test for trend =
2440, P < 0.0001), which is covered in more detail in a
previous report [14]. Primary and secondary diagnoses
were recorded by clinicians at discharge. The most
common discharge diagnoses were anaemia (76%),
P. falciparum malaria (46%) and all types of malnutrition
with 13% (Table 2).
Concurrent with the decline in malaria there was a
marked decline in the prevalence of severe anaemia
(Figure 2) from 2002 to 2009 (chi2 for trend = 134, P <
0.0001). Overall, 8% of admissions in 2002 had severe
anaemia which decreased to < 4% by 2009. The effect
was the most dramatic in infants and young children
where proportions with severe anaemia declined from
10% of admissions to 2%. A steep decline was present in
most age groups except children 5-12 years who showed
Table 1 Main clinical characteristics of admissions by age group
FEATURES Age Groups
Neonates Infant Children 1-4 years Children 5-13 years Total
N (%) 5114 (14) 10167 (28) 16395 (45) 4945 (14) 36621
Age median 3 days 6.5 months 2 years 7.5 years 1.4 years
Male n (%) 2987 (58) 5787 (57) 9122 (56) 2744 (55) 20640 (56)
Malaria parasitemia (%) 18 (0.4) 1284 (13) 5512 (35) 1224 (26) 8038 (23)
Transfused (%) 347 (7) 642 (7) 1338 (9) 395 (8) 2722 (8)
Not transfused (%) 4570 (93) 9073 (93) 14307 (91) 4335 (92) 32285 (92)
Transfusion Missing value 197 452 750 215 1614
Mild or without anaemia (%) 4335 (91) 5127 (53) 7378 (47) 2997 (63) 19837 (56)
Moderate anaemia (%) 359 (8) 4087 (42) 7177 (45) 1414 (30) 13037 (37)
Severe anaemia (%) 91 (2) 526 (5) 1279 (8) 369 (8) 2265 (6)
Haemoglobin value missing 329 427 561 165 1482
Severe anaemia + Respiratory distress (%) 38 (42) 261 (50) 413 (32) 72 (20) 784 (35)
Severe anaemia case fatality (%) 28 (31) 35 (7) 91 (7) 37 (10) 191 (8)
Figure 1 Paediatric admissions with malaria parasitaemia 2002-2009.
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an initial steep decline in prevalence in the years 2002-
2005, which plateaued then rose again in 2008.
Transfusion
Two thousand seven hundred and twenty two children
received a transfusion (7.4%). The majority of transfusions,
55% (1,490), were received by children with severe anae-
mia, 29% (789) were received by children admitted with
moderate anaemia (Hb 5.0-9.3 g/dl) and 14% (375)
received by children who had mild or no anaemia (Hb
>9.3 g/dl) at admission. Two percent of transfusions were
given to children whose Hb values were not recorded on
admission. These relative proportions were constant
throughout the period of the study. The number and pro-
portion of admissions transfused declined significantly
over time (chi2 for trend = 152, P < 0.0001) mirroring the
reduction in severe anaemia (Figure 3). In the 5-12 year
age group, there was an increase in transfusions in 2007-
2009 which was largely accounted for by the increase in
severe anaemia.
Clinical severity of anaemia
Of the 2265 children with severe anaemia 191 (8%) died.
The highest case fatality was in the neonatal group (31%)
(Table 1). There was little difference in mortality in chil-
dren with severe anaemia who received a transfusion, 9%
(129/1490), and those who were not transfused, 8% (59/
737) (Table 3). Admission features of children with severe
anaemia were compared in fatal and non-fatal cases
(Table 3). Respiratory distress was common 784 (24%) and
associated with an elevated mortality of 15% (115/784
patients); children < 1 year being most affected. Deep
‘acidotic’ breathing had a higher case fatality (20%) than
indrawing (14%). Prostration was present in 414 (20%)
and, of these, 20% (81/414 patients) died. Shock (defined
by capillary refilling time> 2 seconds) complicated 460
(20%) cases and 18% (81/460 patients) died. Severe malnu-
trition, incorporating both marasmus (or low gestational
age for newborns) and kwashiorkor complicated 18%
(413/2,265 patients) of cases of severe anaemia with an
overall case fatality of 17% (70/413). Both age and type of
Table 2 Clinicians primary and secondary discharge
diagnosis of children with severe anaemia
Diagnosis Primary Secondary Total (%)
Anaemia 760 960 1720 (76)
Plasmodium falciparum malaria 730 316 1046 (46)
Severe malnutrition 218 66 284 (13)
Lower respiratory tract infection 118 79 197 (9)
Sickle cell disease 148 33 181 (8)
Septicaemia/Sepsis 66 55 121 (5)
Gastroenteritis 33 23 56 (2)
Encephalopathy 16 17 33 (1)
Neonatal jaundice 23 10 33 (1)
HIV exposed or infected 19 39 58 (3)
Other 124 151 275 (12)
Not recorded 10 10 (0.4)
Total 2265 1749
Figure 2 Cases with severe anaemia by age group and year of admission.
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malnutrition (kwashiorkor) affected outcome. Malaria
parasitaemia was most common in infants with severe
anaemia, 1,113 (49%), but rare in neonates. Malaria parasi-
taemia was associated with a lower case fatality 7% (74/
1,118 patients) compared children with any other compli-
cation or co-morbidity.
Mortality over time
Data were examined to determine whether the decline
in malaria, severe anaemia and requirements for transfu-
sion had any bearing on the case fatality rates of severe
anaemia (Figure 2). The absolute number of deaths
from severe anaemia declined due to a reduction in case
Figure 3 Numbers of children receiving a blood transfusion by year and age group.
Table 3 Distribution of severe anaemia and fatality by severity features and age group
CLINICAL FEATURES
Neonates Infants Children 1-4 yrs Children 5-13 yrs Total
n
(%)
CF (%) n
(%)
CF (%) n
(%)
CF
(%)
n
(%)
CF
(%)
N
(%)
CF (%)
N 91 526 1279 369 2265
Age median [IQR] 4 days [2-10] 8 mths [6-10] 2 yrs [1.5-3] 7.5 yrs [6-9.5] 1.9 yrs [0.9-3.6]
Respiratory Distress 38 (42) 12 (32) 261 (50) 27 (10) 413 (32) 59 (14) 72 (20) 17 (24) 784 (24) 115 (15)
Deep Breathing 21 (23) 10 (48) 118 (22) 19 (16) 261 (20) 47 (18) 41 (11) 11 (27) 441 (19) 87 (20)
Indrawing 31 (34) 10 (32) 208 (40) 20 (10) 253 (20) 33 (13) 52 (14) 13 (25) 544 (24) 76 (14)
Capillary refill >2 s 18 (20) 7 (39) 108 (21) 16 (15) 279 (22) 39 (14) 55 (15) 19 (35) 460 (20) 81 (18)
Severe malnutrition 36 (40) 16 (44) 98 (19) 10 (10) 147 (19) 35 (14) 32 (9) 9 (28) 413 (18) 70 (17)
Prostration 16 (18) 6 (38) 85 (16) 18 (21) 277 (22) 48 (17) 36 (10) 9 (25) 414 (18) 81 (20)
Malaria parasites 2 (2) 0 (0) 288 (55) 16 (6) 740 (58) 52 (7) 83 (22) 6 (7) 1113 (49) 74 (7)
Transfused 44 (48) 13 (30) 346 (66) 28 (8) 842 (66) 63 (7) 258 (70) 25 (10) 1490 (66) 129 (9)
Not transfused 47 (52) 15 (32) 164 (31) 6 (4) 423 (33) 27 (6) 103 (28) 11 (11) 737 (33) 59 (8)
No transfusion status 0 16 (3) 1 (6) 14 (1) 1 (7) 8 (2) 1 (13) 38 (2) 3 (8)
CF = Case Fatality.
IQR = Interquartile range.
Respiratory Distress = Deep Breathing or Indrawing.
Severe malnutrition = mid-upper arm circumference <11 cm or kwashiorkor or premature or small for gestational age <2.5 Kg for neonatal group.
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burden however, case fatality remained unchanged dur-
ing this period with an overall mortality of 8% (P <
0.26) (Figure 4). The data were explored to determine
whether this could be explained by changes in the pro-
portions with severe life threatening anaemia. Children
in the high-risk group (life threatening anaemia) were
selected to study trends over time (Table 4). Whilst the
absolute number cases of severe anaemia fell sharply
over the years the proportion of those at high risk
remained unchanged being present in 58-65% of chil-
dren with Hb < 5 g/dl (severe anaemia). Also notable
was that the proportion of life-threatening cases did not
vary with age group - with all post neonatal groups hav-
ing > 60% of cases complicated by severity features.
Discussion
This retrospective study of severe anaemia and transfu-
sion practice has highlighted several important points.
A considerable reduction the clinical burden of severe
anaemia and requirements for transfusions concurrent
with the substantial decline in malaria was noted
between 2002 and 2009. Malaria parasitaemia was
recorded as the leading cause of anaemia and in the
absence of the other complications was associated with
a lower mortality than for non-malarial cases of severe
anaemia. Severe anaemia complicated by deep breathing,
prostration and shock were common and were asso-
ciated with higher case fatalities. Despite the simulta-
neous declines in disease burden (malaria and anaemia)
and demand on transfusion services we found that this
had little effect on the overall case fatality rate of
children admitted with severe anaemia, with mortality
remaining unchanged at 8% throughout the study per-
iod. This was largely explained by the proportion of
children with severe anaemia with life threatening com-
plications, which remained constant over the period of
study, affecting over 60% requiring transfusion.
These data suggest that the impact of reduced malaria
transmission on child morbidity are greater than those
measured by changes in malaria admissions alone. This
is reinforced by Gerritsen and colleagues study in South
Africa (Limpopo) which found a significant reduction of
malaria from 1998 to 2007 [15]. The dramatic reduction
in the numbers with severe anaemia and consequently
the impact on the requirements for blood transfusion
are important ‘value added’ or hidden benefits of malaria
control. Quantifying the reduction in transfusion
requirements from the year 2002, where over 10% of all
children admitted KDH received a blood transfusion
(n = 477) to the year 2009 when only 4% received a
blood transfusion (n = 181), translated to a 2.6 fold
decline. The decrease in blood transfusion requirements,
in addition to reducing the risk of transmissible diseases
and adverse reactions, has an important health eco-
nomic impact. Taking an average range of the cost of
transfusion per child as between 30-50 U.S. Dollars for
voluntary unpaid donors [4], an estimated annual saving
of USD 8,880 to 14,800 for this hospital alone.
There are a number of potential explanations why
reducing the burden of malaria disease and transfusion
requirements did not result in a reduction in case fatality.
First, that the proportion with life threatening anaemia
Figure 4 Cases Fatality of severe anaemia by age group and year.
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did not decline and thus the proportion requiring emer-
gency transfusion remained unchanged. Previous work in
Kilifi in 2000 by English and colleagues demonstrated
that respiratory distress, prostration and profound anae-
mia, were the clinical features most associated with
death, odds ratios of 4.1 (95% CI 2.2 - 7.4), 7.4 (95% CI
4.2-13.1) and 2.5 (95% CI 1-4 - 4.5) respectively [8]. This
data together with that of others indicate no clear asso-
ciation between receipt of transfusion and in-hospital
mortality [16]. However, many of the deaths occur on the
day of admission, in children awaiting transfusion. A pre-
vious report from Siaya, Kenya indicated that transfusion
given after the day of admission had no impact on survi-
val [9]. Currently, 20 ml/kg of whole blood (or 10 ml/kg
packed cells) is recommended for all levels of anaemia
with Hb <6 g/dl [1]. Few data are available on volume of
blood received and indicate only modest rises of mean
haemoglobin 2.5-3.3 g/dl [8,9,17] and with 25% of chil-
dren remaining severely anaemic (< 5 g/dL) [8] following
initial transfusion. Anecdotal evidence from hospitals
suggests that multiple, low volume (20 ml/kg) transfu-
sions are frequently given. Using standard formulae
to calculate volume required [18] the current doses pre-
scribed under-treat children with profound anaemia by
~30%. Larger initial transfusion volumes have not been
systematically evaluated.
Whilst most groups showed a decline in anaemia and
transfusion overtime, there was an increase in children
aged 5-12 years in the years 2008-2009. One possible
suggestion is that other causes of anaemia were becom-
ing more prominent as a cause of admission in this age
group. Unfortunately, in this retrospective study the
degree of fine resolution offered by the recorded final
diagnosis of severe anaemia does not permit a greater
insight into causality.
The effect of introduction of guidelines or protocols
that include rationale transfusion practice, restricting
blood transfusion use to only those at greatest risk has
been examined in several randomized studies in adults,
children and newborns. A review of these meta-analyses
concludes that restrictive strategies reduce the need for
transfusion, in the UK, without increasing morbidity and
mortality [19]. Compliance with WHO paediatric guide-
lines for rationale use of blood transfusion at Kilifi Dis-
trict Hospital is still sub-optimal. Only 55% of patients
had anaemia or a degree of severity at admission that
would qualify for transfusion if the protocol had been
adhered to. The rest of the transfusions were received by
children who had moderate, mild or no anaemia at
admission. Little change in practice was noted through-
out the study period. Finally, it was not possible to differ-
entiate exchange transfusion from transfusion for
anaemia in the newborn group. This study had design
limitations of that did not allow us to track haemoglobin
or markers of severity after admission to know what
motivated physicians to transfuse these children. Other
studies have shown that strict introduction of strict con-
sensus guidelines was insufficient to change prescribing
practice, without regular audit and supervision by senior
medical staff [20].
Conclusions
The consequence of a reduction in the number and pro-
portion of cases admitted with falciparum malaria was a
decrease in the burden of severe malarial anaemia and a
reduction in the demand for paediatric transfusion.
Although the reduced malaria burden leads to a wel-
come reduction in the transfusion requirement the case
fatality for those admitted with severe anaemia remains
unacceptably high. The most recent systematic reviews
[2,21] indicated the need for formal evaluation of the
rationale transfusion policy in a controlled trial. Further
research to establish best transfusion practice and iden-
tify other treatment strategies aimed at reducing in
Table 4 Severe anaemia complicated by Deep breathing, Prostration or Profound anaemia
Year
Neonates Infants Children 1-4 yrs Children 5-13 yrs Total
n D.P.P (%) n D.P.P(%) n D.P.P (%) n D.P.P (%) N D.P.P (%)
2002 10 4 (40) 106 70 (66) 261 172 (66) 69 42 (61) 446 288 (65)
2003 15 7 (47) 135 76 (56) 303 199 (66) 74 50 (68) 527 332 (63)
2004 11 4 (36) 96 63 (66) 183 121 (66) 39 27 (69) 329 215 (65)
2005 15 7 (47) 65 33 (51) 160 98 (61) 35 22 (63) 275 160 (58)
2006 19 10 (53) 50 30 (60) 126 81 (64) 38 25 66) 233 146 (63)
2007 7 0 (0) 30 19 (63) 105 69 (66) 34 25 (74) 176 113 (64)
2008 6 2 (33) 26 13 (50) 83 53 (64) 49 34 (69) 164 102 (62)
2009 8 3 (38) 18 12 (67) 58 40 (69) 31 20 (65) 115 75 (65)
Total 91 37 (41) 526 316 (60) 1279 833 (65) 369 245 (66) 2265 1431 (63)
n = Number of severe anaemia cases.
D.P.P = Number of cases complicated by deep Breathing or Prostration or Profound anaemia (Hb <4 g/dl).
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hospital mortality is essential in this common paediatric
condition in sub-Saharan Africa.
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